Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/10/2018 |
| Start Date: | September 2005 |
| End Date: | December 2019 |
The study investigates the possibility that levetiracetam may improve the symptoms of chronic
post-stroke aphasia.
post-stroke aphasia.
In the study, 50 post-stroke subjects with aphasia will take levetiracetam and we will
evaluate their speech, language, and memory in an ABAB design.
evaluate their speech, language, and memory in an ABAB design.
Inclusion Criteria:
- Stroke
- Aphasia
- Can give consent
Exclusion Criteria:
- Renal failure
- Pregnancy
- Other neurological condition
We found this trial at
1
site
Click here to add this to my saved trials
